Literature DB >> 7937979

Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system.

M L Hedley1, R G Urban, J L Strominger.   

Abstract

In vitro transcription/translation of HLA-DR1 cDNAs in the presence of microsomal membranes was used to study the association of major histocompatibility complex class II molecules with peptide and invariant chain (Ii) in the endoplasmic reticulum (ER). HLA-DR alpha and HLA-DR beta subunits assembled into SDS-unstable heterodimers in the absence of exogenous peptide. The inclusion of synthetic peptides during the alpha/beta assembly process promoted their conversion to SDS-resistant heterodimers. Addition of Ii RNA during the translation of HLA-DR alpha and HLA-DR beta RNAs resulted in the formation of alpha/beta/Ii complexes. Peptide binding by class II molecules was detected even when excess Ii was present during alpha/beta assembly. These findings indicate that peptides can bind alpha/beta heterodimers in the ER microenvironment and suggest that peptides derived from cytosolic proteins that are presented by class II molecules at the cell surface may have bound to HLA-DR in the ER.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937979      PMCID: PMC45044          DOI: 10.1073/pnas.91.22.10479

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Independent and synergistic effects of disulfide bond formation, beta 2-microglobulin, and peptides on class I MHC folding and assembly in an in vitro translation system.

Authors:  R K Ribaudo; D H Margulies
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

2.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.

Authors:  J M Riberdy; J R Newcomb; M J Surman; J A Barbosa; P Cresswell
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

3.  Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.

Authors:  H J Zweerink; M C Gammon; U Utz; S Y Sauma; T Harrer; J C Hawkins; R P Johnson; A Sirotina; J D Hermes; B D Walker
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

4.  Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.

Authors:  A G Brooks; J McCluskey
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

5.  Identification of two distinct properties of class II major histocompatibility complex-associated peptides.

Authors:  C A Nelson; S J Petzold; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

6.  Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.

Authors:  J R Newcomb; P Cresswell
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

7.  Mice lacking the MHC class II-associated invariant chain.

Authors:  S Viville; J Neefjes; V Lotteau; A Dierich; M Lemeur; H Ploegh; C Benoist; D Mathis
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

8.  The assembly of H2-Kb class I molecules translated in vitro requires oxidized glutathione and peptide.

Authors:  M J Bijlmakers; J J Neefjes; E H Wojcik-Jacobs; H L Ploegh
Journal:  Eur J Immunol       Date:  1993-06       Impact factor: 5.532

9.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.

Authors:  E K Bikoff; L Y Huang; V Episkopou; J van Meerwijk; R N Germain; E J Robertson
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  6 in total

1.  Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas.

Authors:  H J Hansen; G L Ong; H Diril; A Valdez; P A Roche; G L Griffiths; D M Goldenberg; M J Mattes
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

2.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

3.  Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP).

Authors:  G Zhong; F Castellino; P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

4.  Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding.

Authors:  H Kropshofer; A B Vogt; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

5.  Folding of hepatitis C virus E1 glycoprotein in a cell-free system.

Authors:  M Merola; M Brazzoli; F Cocchiarella; J M Heile; A Helenius; A J Weiner; M Houghton; S Abrignani
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Inhibition of invariant chain (Ii)-calnexin interaction results in enhanced degradation of Ii but does not prevent the assembly of alpha beta Ii complexes.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.